Headlines
-
Guild, Nectr deal to start
Wednesday | Jan 24 2024THE Pharmacy Guild member-exclusive energy deal with Nectr will be commencing on 12 Feb.
-
Heatwave safety campaign launched
Wednesday | Jan 24 2024SWELTERING Cities, a new heat safety campaign is calling on people to check in on friends, family and other people who might be at risk this summer.
-
NAPSA 2024 inspires future generation
Tuesday | Jan 23 2024THE National Association of Pharmacy Students (NAPSA) Congress 2024 set the stage for discussions on the scope of practice impacting the future of the profession, led by Pharmacy Guild National President Trent Twomey, while National Vice President Helen O'Byrne presented to students the latest on pharmacy workforce issues.
-
Life boosts remote health
Tuesday | Jan 23 2024LIFE Pharmacy Group (LPG) pharmacists administered 479 COVID-19 vaccinations to aged care residents at 10 regional and remote sites across New South Wales during the Christmas/New Year period.
-
RSV vax access critical
Monday | Jan 22 2024THE PSA is calling on all Govts to allow pharmacists to administer the recently approved first respiratory syncytial virus (RSV) vaccine, as it would "significantly improve its uptake" and reduce hospitalisations from severe infections.
-
NAPSA Wildcard winner
Monday | Jan 22 2024THE Pharmacy Student of the Year Wildcard entry has been awarded to McKinlay Nolan from the University of Tasmania last Fri at the National Australian Pharmacy Students Association Congress in Hobart.
-
Tas palliative care program launched
Friday | Jan 19 2024EIGHTY-THREE pharmacies have signed up to ensure palliative care patients in Tas who choose to stay at home can readily access end-of life medications from their local community pharmacy as needed, with more to come on board.
-
No news of 8CPA progress
Friday | Jan 19 2024LACK of progress on the 8th Community Pharmacy Agreement (8CPA) from the Federal Govt has been flagged by spokesperson for the Community and Pharmacy Support Group (CAPS), Emil Demyane, in a video where he also emphasised the significance of the Canberra protest planned for the 06 Feb (PD 10 Jan).
-
Prota raises over $31m for allergy drug
Thursday | Jan 18 2024PROTA Therapeutics Pty Ltd (Prota), an Australian biotechnology company, has raised US$21 million (A$31.97m) to support the clinical development and commercialisation of its treatment for peanut allergy in children.
-
Editor’s Choice: pots that build a dewy finish at easy prices
Thursday | Jan 18 2024BRITISH-BASED beauty brand, Makeup Revolution, known for its cosmetic products at cost-of-living-friendly prices, has introduced new Balm Glow products to suit all.